SCHEMBL7546501

SCHEMBL7546501

CCC(C)C(CC)C(C(=O)O)C(C)CC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.41
ACE P12821 3/20 0.39
MME P08473 2/20 0.39
CPA1 P15085 2/20 0.39
ACE2 Q9BYF1 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.35
TP53 P04637 1/20 0.35
CHRM1 P11229 1/20 0.33
AKR1A1 P14550 1/20 0.33
CHRM3 P20309 1/20 0.33
HTR2A P28223 1/20 0.33
HTR2C P28335 1/20 0.33
ADRA1A P35348 1/20 0.33
HRH1 P35367 1/20 0.33
DRD3 P35462 1/20 0.33
SLC6A3 Q01959 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC2 Q92769 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
CA2 P00918 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7546505 1.00 ALDH1A1 (0.41) ALDH1A1ACEMMECPA1ACE2
SCHEMBL28090209 0.87 ALDH1A1 (0.45) ALDH1A1ACEMMECPA1ACE2
SCHEMBL6231002 0.87 ALDH1A1 (0.36) ALDH1A1ACEMMECPA1ACE2
SCHEMBL3499612 0.82 ALDH1A1 (0.42) ALDH1A1ACEMMECPA1ACE2
SCHEMBL13311446 0.82 ALDH1A1 (0.42) ALDH1A1ACEMMECPA1ACE2
SCHEMBL2625119 0.80 ALDH1A1 (0.41) ALDH1A1ACEMMECPA1ACE2
SCHEMBL8569856 0.80 TP53 (0.41) ALDH1A1ACEMMECPA1ACE2
SCHEMBL20753231 0.80 ALDH1A1 (0.41) ALDH1A1ACEMMECPA1ACE2
SCHEMBL30751935 0.80 ALDH1A1 (0.41) ALDH1A1ACEMMECPA1ACE2
SCHEMBL13145129 0.78 TSHR (0.41) ALDH1A1ACEMMECPA1ACE2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020156320-A1 Enantioselective synthesis of valproic acid analogues NAU HEINZ (DE) 2002-10-24 US claimed
US-20020156320-A1 Enantioselective synthesis of valproic acid analogues NAU HEINZ (DE) 2002-10-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020156320-A1 Enantioselective synthesis of valproic acid analogues COASY, ACADM, CYP2A6 ALDH1A1 422/4885ACE 155/4885MME 3372/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.